Antibody-dependent cellular cytotoxicity against SARS-CoV-2 variants of concern

针对值得关注的 SARS-CoV-2 变体的抗体依赖性细胞毒性

• 批准号: 466724
• 负责人: Benlarbi Mehdi
• 金额: $ 1.27万
• 依托单位: Universit de Montral
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-12-01 至 2022-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=466724&lang=en
• 关键词: Antibodies; Antibody Fc Effector Functions; Antibody-Dependent Cellular Cytotoxicity (Adcc); Covid-19; Humoral Response; Immune System; Plasma; Sars-Cov-2; Vaccine; Variants Of Concern (Voc)

In December 2019, several pneumonia outbreaks emerged in China, all related to the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The high transmissibility of SARS-CoV-2 caused the current devastating pandemic of coronavirus disease 2

2019年12月，中国出现了几起肺炎疫情，均与新型严重急性呼吸道综合征冠状病毒2（SARS-CoV-2）有关。SARS-CoV-2的高传播性导致了目前冠状病毒病2的毁灭性大流行